Implementing these programs under Africa CDC leadership will enhance disease surveillance systems, expand laboratory infrastructure, and foster deeper partnerships with leading European research institutions.
The contract includes multiyear options that could ultimately deliver up to USD 482 million if exercised, enabling Shionogi to establish a dedicated manufacturing facility in the United States.
BioNTech’s decision follows a comprehensive strategic review aimed at aligning the company’s manufacturing capacity with its clinical pipeline and long-term business direction
Exhibitions & Trade Services India Private Limited (ETSIPL) will manage the event’s organization and execution.
The two companies began collaborating in 2024 through an option and license agreement valued at up to USD 465 million, which granted Gilead access to Tubulis’ proprietary ADC platforms.
Three Moscow hospitals tested the system and achieved strong results: the algorithm identified quality problems with 94% accuracy and detected data errors in 99% of cases.
The plan itself serves as a practical guide for improving Ghana’s health defenses across multiple fronts, from enhancing laboratory capabilities to strengthening border health measures.
McKinsey predicts that healthcare spending will rise from USD 11.2 trillion today to USD 20.5 trillion by 2050, owing primarily to the nearly doubling of the population over the age of 65.
The drug works as a once-daily glucagon-like peptide-1 (GLP-1) receptor agonist, requiring no food or water restrictions before taking it.
The collaboration targets two key challenges with MSD’s existing Zaire Ebola vaccine: complex manufacturing requirements and the need for ultra-cold storage.